Dr. Carleton J.C. Hsia

Chairman & Chief Executive Officer

Dr. Carleton Hsia is a serial entrepreneur, inventor and former university professor. The companies he founded included Hemosol Inc, SynZyme Technologies, NanoBlood and AntiRadical Therapeutics. He has been President & CEO of NanoBlood since 2013. He was the inventor of Hemosol's HemoLink technology. His most recent invention is caged nitric oxide (CNO) nanotechnology and NanoBlood's nanoRBC (nano red blood cell) for use as a superoxide and hemoglobin taming drug. Working in the realm of quantum physics, Dr. Hsia is founding an entirely new field of NanoQuantum Medicine, which should have a major effect on worldwide health as well as producing economic and political benefit beyond that of current Digital Medicine. Contact Carleton at chsia[at]

Bohdan Soltys MBA PhD

Dr. Bohdan Soltys, MBA PhD

Chief Operating Officer

Dr. Soltys began in industry as an R&D scientist at GE Healthcare and has 13  years of experience in management of biotech, medical device and software comapanies in the Life Sciences, including small companies in ramp-up mode and larger companies. As COO at NanoBlood, Bohdan is managing business develeopment, operations, collaborative research programs and regulatory submissions in taking SanFlow through clinical trials, investment rounds, and onto the market. Contact Bohdan at bohdan[at]